资讯
Singaporean students talk about their experiences with classmates cheating to get an unfair edge. Read more at ...
DO-2 is a Best in Class MET kinase inhibitor that completed enrolling a Phase 1 dose escalation study. Tumour shrinkage is observed in 100% of MET exon 14 skip NSCLC patients without additional ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果